ARTICLE | Clinical News
Fluticasone propionate/salmeterol regulatory update
July 11, 2016 7:00 AM UTC
FDA accepted for review NDAs from Teva for fluticasone propionate and fluticasone propionate/salmeterol delivered via the RespiClick breath-actuated, multidose dry powder inhaler (MDPI) to treat asthm...